[go: up one dir, main page]

DK0929525T3 - Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor - Google Patents

Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor

Info

Publication number
DK0929525T3
DK0929525T3 DK97943000T DK97943000T DK0929525T3 DK 0929525 T3 DK0929525 T3 DK 0929525T3 DK 97943000 T DK97943000 T DK 97943000T DK 97943000 T DK97943000 T DK 97943000T DK 0929525 T3 DK0929525 T3 DK 0929525T3
Authority
DK
Denmark
Prior art keywords
heteroberloxyethylamines
ligands
ht1a receptor
ht1a
receptor
Prior art date
Application number
DK97943000T
Other languages
Danish (da)
English (en)
Inventor
Denis Bigg
Marie-Odile Galcera
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0929525T3 publication Critical patent/DK0929525T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK97943000T 1996-09-27 1997-09-26 Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor DK0929525T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611798A FR2753968B1 (fr) 1996-09-27 1996-09-27 Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
PCT/FR1997/001691 WO1998013349A2 (fr) 1996-09-27 1997-09-26 Heteroaryloxyethylamines en tant que ligands 5-ht¿1a?

Publications (1)

Publication Number Publication Date
DK0929525T3 true DK0929525T3 (da) 2002-12-02

Family

ID=9496126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97943000T DK0929525T3 (da) 1996-09-27 1997-09-26 Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor

Country Status (21)

Country Link
US (1) US6063784A (zh)
EP (1) EP0929525B1 (zh)
JP (1) JP2001503393A (zh)
AR (1) AR008486A1 (zh)
AT (1) ATE223380T1 (zh)
AU (1) AU731459B2 (zh)
BR (1) BR9711560A (zh)
CA (1) CA2267247C (zh)
DE (1) DE69715223T2 (zh)
DK (1) DK0929525T3 (zh)
ES (1) ES2182120T3 (zh)
FR (1) FR2753968B1 (zh)
HU (1) HUP0001189A3 (zh)
IL (1) IL128917A (zh)
MY (1) MY118992A (zh)
NO (1) NO311935B1 (zh)
NZ (1) NZ334623A (zh)
PL (1) PL190221B1 (zh)
RU (1) RU2176639C2 (zh)
TW (1) TW425390B (zh)
WO (1) WO1998013349A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4507398B2 (ja) * 1999-12-06 2010-07-21 宇部興産株式会社 ３−ハロメチルオキセタン化合物の合成方法
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
US5240800A (en) * 1991-07-29 1993-08-31 Eastman Kodak Company Near-infrared radiation sensitive photoelectrographic master and imaging method
GB9507288D0 (en) * 1995-04-07 1995-05-31 Sod Conseils Rech Applic Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors

Also Published As

Publication number Publication date
US6063784A (en) 2000-05-16
CA2267247C (fr) 2009-05-05
DE69715223D1 (de) 2002-10-10
HUP0001189A2 (hu) 2000-10-28
NO991481L (no) 1999-03-26
CA2267247A1 (fr) 1998-04-02
ATE223380T1 (de) 2002-09-15
EP0929525B1 (fr) 2002-09-04
PL332480A1 (en) 1999-09-13
IL128917A (en) 2003-10-31
WO1998013349A3 (fr) 1998-11-05
BR9711560A (pt) 1999-08-24
MY118992A (en) 2005-02-28
EP0929525A2 (fr) 1999-07-21
ES2182120T3 (es) 2003-03-01
JP2001503393A (ja) 2001-03-13
NO991481D0 (no) 1999-03-26
PL190221B1 (pl) 2005-11-30
AU4463797A (en) 1998-04-17
IL128917A0 (en) 2000-02-17
FR2753968B1 (fr) 1998-11-27
AU731459B2 (en) 2001-03-29
HUP0001189A3 (en) 2001-12-28
RU2176639C2 (ru) 2001-12-10
NO311935B1 (no) 2002-02-18
FR2753968A1 (fr) 1998-04-03
NZ334623A (en) 1999-09-29
WO1998013349A2 (fr) 1998-04-02
TW425390B (en) 2001-03-11
AR008486A1 (es) 2000-01-19
DE69715223T2 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
DK0908449T3 (da) Fremstilling af carotenoider
EE200000044A (et) Uued ühendid
DK1032566T5 (da) Fremgangsmåde til fremstilling af citalopram
IS5430A (is) Ný samsetning
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
PT906288E (pt) Novos compostos
DK0911311T3 (da) Fremstilling af lycopenmetabolitter
NO994106D0 (no) Oksazolidiner som 5-HT2A-antagonister
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
FI970727A0 (fi) Foerfarande och anordning foer torkning av objekt som innehaoller vatten
NO983656D0 (no) Heterocyklyl-ergolinderivater som 5-HT1A reseptorligander
DK0929525T3 (da) Heteroaryloxyethylaminer som ligander af 5-HT1A-receptor
DK0915076T3 (da) Fremgangsmåde til fremstilling af trans-(R,R)-actinol
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
DK0921111T3 (da) Fremgangsmåde til fremstilling af substituerede anthraquinoner
FI980053A0 (fi) Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem
DE69827603D1 (de) Synchrondemodulator
FI973491A0 (fi) Markeringsmaolning och distributionsfoerpackning som anvaender en laogtrycksbehaollare foer densamma
KR960005287U (ko) 건축, 토목용 비계 설치구
DK0938330T3 (da) Anvendelse af LH-RH antagonister som diagnostisk middel
DK0882035T3 (da) Fremgangsmåde til fremstilling af 2H-1-benzopyraner
DK0817613T3 (da) Anvendelse af præparater, som omfatter stabiliserede enzymer